A recent study suggests that mushroom extract containing psilocybin may exhibit superior efficacy when compared to chemically synthesized psilocybin. The findings are published in the journal Molecular Psychiatry.
Mar 11, 2024
0
82
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential clues to why some ...
Mar 7, 2024
0
597
Males and females have differential physiological responses to COVID-19 infections, with males having larger increases in skin temperature, breathing rate and heart rate during an acute infection. That is the conclusion of ...
Mar 6, 2024
0
18
Many childhood cancers start with a hijacking at the molecular level. A group of abnormal proteins known as fusion proteins aberrantly engages with a collection of proteins that switches genes on and off. As a result, genes ...
Mar 6, 2024
0
60
An endoscopic mapping device, developed over the course of a decade by scientists at the Auckland Bioengineering Institute, consists of an inflatable sphere covered in sensors, delivered down the esophagus and able to measure ...
Mar 6, 2024
0
18
Harnessing a pervasive type of cellular messenger shows early experimental promise as a routine way of sampling and monitoring the body's response to prescription drug exposure.
Mar 5, 2024
0
15
A new Danish study may be the first step towards a much faster and more accurate diagnosis of a wide range of conditions that require regulation of the body's stress hormone, cortisol.
Mar 1, 2024
0
43
Chimeric antigen receptor (CAR)-T cell therapy is a potent emerging weapon against cancer, altering patients' T cells so they can better find and destroy tumor cells. But CAR-T cell therapy doesn't work well in every cancer—including ...
Mar 1, 2024
0
9
Drug discovery can be a frustrating process of trial and error. Scientists using fragment-based drug discovery link fragments of different molecules together to create a more potent drug but may not know whether a compound ...
Feb 28, 2024
0
10
Research targeting the insulin-inhibitory receptor, or inceptor, unveils promising avenues for beta cell protection, offering hope for causal diabetes therapy.
Feb 28, 2024
0
15
